Asia-Pacific Dry Eye Syndrome Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Jul 2019
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 201
  • No of Figures: 28

Asia-Pacific Dry Eye Syndrome Market By Product Type (Tear stimulators, Artificial tears, Secretagogue, Others), Dosage Type ( Liquid, Semi-solid, Others ), Drug Class( Lubricating Agents, Cholinergics, Anti-Inflammatory, Anti-Infectives, Anti-Allergics, Others ), Dose( Unit dose, Multi-dose ), Medication Type( Prescription (Rx) Drugs, Over The Counter (OTC) Drugs ), Container Type( Unit-Dose Vials, Bottles, Tubes ), Packaging Type( Plastic, Aluminium, Glass ), Type (Brands, Generics), End Users ( Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) – Industry Trends and Forecast to 2026

Dry eye is a multifactorial disease of the tears and ocular surface that causes symptoms of disquiet visual disturbance and tears film variability with possible damage to the ocular surface. It is escorted increase in tear film osmolality and ocular surface inflammation which may result in substantial damage of eye. The symptoms of dry eye syndrome includes eye redness, blurred vision and eye fatigue, watery eyes, which is the body's response to the irritation of dry eyes such as a stinging burning and scratchy sensation in eyes.

Asia-Pacific dry eye syndrome market is projected to register a substantial CAGR in the forecast period 2019 to 2026.

Segmentation: Asia-Pacific Dry Eye Syndrome Market

Asia-Pacific dry eye syndrome market is segmented into ten notable segments which are basis of product type, dosage type, drug class, dose, medication type, container type, packaging type, type, end user and distribution channel.

·         On the basis of product type, the market is segmented into tear stimulators, artificial tears, secretagogue and others

·         On the basis of dosage type, the market is segmented into liquid, semi solid and others

·         On the basis of drug class, the market is segmented into anti-inflammatory, lubricating agents, anti-infectives, anti-allergics, cholinergic and others

·         On the basis of dose, the market is segmented into multi dose and unit dose

·         On the basis of medication type, the market is segmented into prescription (RX) drugs, and over the counter (OTC) drugs

·         On the basis of container type, the market is segmented into unit dose vials, bottles, and tubes

·         On the basis of packaging type, the market is segmented into plastic, glass, and aluminium

·         On the basis of type, the market is segmented into generics and brands

·         On the basis of end user, the market is segmented into home healthcare, hospitals, clinics, and others

·         On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others

Competitive Analysis: Asia-Pacific Dry Eye Syndrome Market

Some of the major players operating in Asia-Pacific dry eye syndrome market are Allergan, Bausch & Lomb Incorporated, Novartis Ag, Johnson & Johnson Services, Inc., Prestige Consumer Healthcare, Inc., Akorn, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Novaliq Gmbh, Santen Pharmaceutical Co., Ltd., Cardinal Health, Alembic Pharmaceuticals Limited., Cipla Inc., Perrigo Company Plc, Senju Pharmaceutical Co. Ltd., Horus Pharma, Rohto Pharmaceutical Co., Ltd., Visufarma, Hubrx and others.

Recent Developments

·         In July 2019, Sun Ophthalmics which is a division of the Sun Pharmaceutical Industries, Inc. will be attending the AECOS (summer meeting) from 11th July to 14th July in U.S. This strategy would help the company to enhance its customer base.

·         In November 2018, ROHTO Pharma (India) Private Limited subsidiary of Rohto Pharmaceutical Co., Ltd has launched its Cooling Eye Drops range in India. This drug will help to treat dry eyes disease. It is having cooling formula to relief eye redness and irritated eyes. The major advantage of this launch is that it will help to grow eye care market as ROHTO Cooling Eye Drops was No. 1 OTC eye drop brand in Asia-Pacific market and listed in Guinness World Record 2014.

·         In August 2018, Sun Pharmaceutical Industries Ltd. (India) has received approval for its first dry eye drug Cequa from the FDA. Through this FDA approval, Sun Pharma has entered into dry eye treatment market. It is highest FDA-approved concentration of cyclosporine A (CsA) and first and only approved CsA product that incorporates a nanomicellar technology.

Research Methodology : Asia-Pacific Dry Eye Syndrome Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Bakers and Food Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers.


SKU-

TABLE 1 AGEING WORLD POPULATION

TABLE 2 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 3 ASIA-PACIFIC TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 4 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 5 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 6 ASIA-PACIFIC LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 7 ASIA-PACIFIC LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 8 ASIA-PACIFIC SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 9 ASIA-PACIFIC DIGITAL IN DRY EYE SYNDROME MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)

TABLE 10 ASIA-PACIFIC OTHERS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 11 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 12 ASIA-PACIFIC ANTI-INFLAMMATORY IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 ASIA-PACIFIC LUBRICATING AGENT IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 ASIA-PACIFIC ANTI-INFECTIVE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 ASIA-PACIFIC ANTI-ALLERGIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 ASIA-PACIFIC CHOLINERGIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 ASIA-PACIFIC OTHERS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 19 ASIA-PACIFIC MULTI DOSE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 ASIA-PACIFIC UNIT DOSE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 22 ASIA-PACIFIC PRESCRIPTION (RX) DRUGS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 25 ASIA-PACIFIC UNIT DOSE VIALS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 ASIA-PACIFIC BOTTLES IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 ASIA-PACIFIC TUBES IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 29 ASIA-PACIFIC PLASTIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 ASIA-PACIFIC GLASS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 ASIA-PACIFIC ALUMINUM IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 33 ASIA-PACIFIC GENERICS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 34 ASIA-PACIFIC BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 35 ASIA-PACIFIC BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 36 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 37 ASIA-PACIFIC HOME HEALTHCARE IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 38 ASIA-PACIFIC HOSPITALS IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 39 ASIA-PACIFIC CLINICS IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 40 ASIA-PACIFIC OTHERS IN DRY EYE SYNDROME MARKET, BY END USER, 2016-2026 (USD MILLION)

TABLE 41 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 42 ASIA-PACIFIC HOSPITAL PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 43 ASIA-PACIFIC RETAIL PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 44 ASIA-PACIFIC ONLINE PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 45 ASIA-PACIFIC OTHERS IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2016-2026 (USD MILLION)

TABLE 46 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 47 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 48 ASIA-PACIFIC TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 49 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 50 ASIA-PACIFIC LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 51 ASIA-PACIFIC SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 52 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 53 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 54 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 55 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 56 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 57 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 58 ASIA-PACIFIC BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 59 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 60 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 61 JAPAN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 62 JAPAN TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 63 JAPAN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 64 JAPAN LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 65 JAPAN SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 66 JAPAN DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 67 JAPAN DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 68 JAPAN DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 69 JAPAN DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 70 JAPAN DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 71 JAPAN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 72 JAPAN BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 73 JAPAN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 74 JAPAN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 75 CHINA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 76 CHINA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 77 CHINA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 78 CHINA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 79 CHINA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 80 CHINA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 81 CHINA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 82 CHINA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 83 CHINA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 84 CHINA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 85 CHINA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 86 CHINA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 87 CHINA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 88 CHINA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 89 INDIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 90 INDIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 91 INDIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 92 INDIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 93 INDIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 94 INDIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 95 INDIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 96 INDIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 97 INDIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 98 INDIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 99 INDIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 100 INDIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 101 INDIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 102 INDIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 103 SOUTH KOREA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 104 SOUTH KOREA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 105 SOUTH KOREA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 106 SOUTH KOREA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 107 SOUTH KOREA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 108 SOUTH KOREA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 109 SOUTH KOREA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 110 SOUTH KOREA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 111 SOUTH KOREA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 112 SOUTH KOREA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 113 SOUTH KOREA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 114 SOUTH KOREA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 115 SOUTH KOREA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 116 SOUTH KOREA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 117 AUSTRALIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 118 AUSTRALIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 119 AUSTRALIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 120 AUSTRALIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 121 AUSTRALIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 122 AUSTRALIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 123 AUSTRALIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 124 AUSTRALIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 125 AUSTRALIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 126 AUSTRALIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 127 AUSTRALIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 128 AUSTRALIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 129 AUSTRALIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 130 AUSTRALIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 131 SINGAPORE DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 132 SINGAPORE TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 133 SINGAPORE DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 134 SINGAPORE LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 135 SINGAPORE SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 136 SINGAPORE DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 137 SINGAPORE DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 138 SINGAPORE DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 139 SINGAPORE DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 140 SINGAPORE DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 141 SINGAPORE DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 142 SINGAPORE BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 143 SINGAPORE DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 144 SINGAPORE DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 145 THAILAND DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 146 THAILAND TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 147 THAILAND DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 148 THAILAND LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 149 THAILAND SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 150 THAILAND DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 151 THAILAND DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 152 THAILAND DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 153 THAILAND DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 154 THAILAND DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 155 THAILAND DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 156 THAILAND BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 157 THAILAND DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 158 THAILAND DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 159 MALAYSIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 160 MALAYSIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 161 MALAYSIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 162 MALAYSIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 163 MALAYSIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 164 MALAYSIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 165 MALAYSIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 166 MALAYSIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 167 MALAYSIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 168 MALAYSIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 169 MALAYSIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 170 MALAYSIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 171 MALAYSIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 172 MALAYSIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 173 INDONESIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 174 INDONESIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 175 INDONESIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 176 INDONESIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 177 INDONESIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 178 INDONESIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 179 INDONESIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 180 INDONESIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 181 INDONESIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 182 INDONESIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 183 INDONESIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 184 INDONESIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 185 INDONESIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 186 INDONESIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 187 PHILIPPINES DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 188 PHILIPPINES TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 189 PHILIPPINES DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 190 PHILIPPINES LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 191 PHILIPPINES SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 192 PHILIPPINES DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 193 PHILIPPINES DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 194 PHILIPPINES DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 195 PHILIPPINES DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 196 PHILIPPINES DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 197 PHILIPPINES DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 198 PHILIPPINES BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 199 PHILIPPINES DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 200 PHILIPPINES DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 201 REST OF APAC DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE